PRGTX
Price
$37.83
Change
+$0.17 (+0.45%)
Updated
Jun 22 closing price
Net Assets
8.63B
WFSTX
Price
$11.37
Change
+$0.10 (+0.89%)
Updated
Jun 22 closing price
Net Assets
376.77M
Interact to see
Advertisement

PRGTX vs WFSTX

PRGTX vs WFSTX Comparison Chart in %
View a ticker or compare two or three
VS
PRGTX vs. WFSTX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRGTX is a Buy and WFSTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRGTX has more cash in the bank: 8.63B vs. WFSTX (377M). PRGTX (0.00) and WFSTX (0.00) have matching dividends . PRGTX was incepted earlier than WFSTX: PRGTX (26 years) vs WFSTX (26 years). WFSTX (1.30) is less costly to investors than PRGTX (0.93). WFSTX (35.00) and PRGTX (34.60) have comparable annual turnover. WFSTX has a lower initial minimum investment than PRGTX: WFSTX (1000) vs PRGTX (2500). PRGTX annual gain was more profitable for investors over the last year : 74.68 vs. WFSTX (-6.24). PRGTX return over 5 years is better than : 20.05 vs. WFSTX (-43.51).
PRGTXWFSTXPRGTX / WFSTX
Total Expense Ratio0.931.2276%
Annual Report Gross Expense Ratio0.931.3072%
Fund Existence26 years26 years-
Gain YTD41.84610.599395%
Front LoadN/A6%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets8.63B377M2,289%
Annual Yield % from dividends0.000.00-
Returns for 1 year74.68-6.24-1,197%
Returns for 3 years170.1618.63913%
Returns for 5 years20.05-43.51-46%
Returns for 10 years188.8023.17815%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTR65.704.72
+7.74%
Nektar Therapeutics
SGMT7.100.42
+6.29%
Sagimet Biosciences
CCNEP24.75N/A
N/A
CNB Financial Corp
NYT72.08-0.98
-1.34%
New York Times Co
LNSR5.64-0.11
-1.83%
LENSAR